Options Trades in CME & MRVL as NVDA Lifts Tech Sector

Options strategist Tony Zhang points to broad tech strength as Nvidia (NVDA) “gives new life” to the sector, framing continued upside even if markets face another volatility wave. He highlights options opportunities in CME Group (CME) and Marvell (MRVL) and maintains a bull case for both names despite expected choppiness.

Analysis

The near-term winner is the AI supply chain beta basket, not just NVDA itself. When NVDA reasserts leadership, it tends to pull in semis and networking names with it, but the second-order effect is dispersion: money rotates toward the few suppliers with visible AI exposure while legacy compute and lower-quality hardware names get crowded out. MRVL is levered to that theme, but its upside is more dependent on the market believing AI capex remains a 2-4 quarter story rather than a one-quarter hype trade.

CME is a different expression: it benefits if this tech-led move keeps realized and implied volatility elevated, because that supports futures/options turnover and hedging demand. The risk is that if NVDA stabilizes the tape and breadth improves, vol can mean-revert quickly, which would make CME’s “volatility wave” thesis less attractive within days to weeks. In other words, CME is best viewed as a volatility hedge with operating leverage to market stress, not a pure AI momentum trade.

The consensus may be underpricing how quickly the trade can reverse if the market decides this is just a short-covering burst in mega-cap tech. Over 1-3 months, the key catalyst is whether NVDA confirms new highs with broad semis participation; if it does not, MRVL can lag despite positive sentiment. Over 6-18 months, the structural winner remains the picks-and-shovels AI infrastructure complex, but only names with durable margins and customer diversification will deserve multiple expansion.

Key Decisions for Investors

• Initiate a small long CME position as a volatility hedge for the book; best entry is after a 1-2 day equity rally when front-end vol is still bid. Falsify if VIX breaks lower and stays subdued for several sessions, or if options/futures activity fails to expand.
• Trade MRVL only on confirmation, not anticipation: buy a starter position on any pullback that holds relative strength vs. SOXX/NVDA. Risk/reward improves if management commentary confirms AI revenue acceleration; otherwise this is a crowded beta expression with limited upside in a vol crush.
• Pair long CME / short a broad tech ETF or high-beta semis basket if the tape remains choppy. The thesis is that dispersion and hedging demand outperform outright index beta over the next 2-6 weeks.
• Use NVDA strength as a timing signal for MRVL, not a substitute for fundamentals; if NVDA rallies while MRVL underperforms, treat that as a warning that the AI spend trade is narrowing and trim exposure.
• Watch for a broadening confirmation in SOXX/XSD over the next 1-3 months; if leadership stays concentrated in NVDA alone, expect the move to fade and avoid chasing the secondaries.